These gold assets are priced for $1,800 gold [it's over $4,000] (From Golden Portfolio)

Markets have been on a wild ride this summer, with the S&P 500 finally making a new all-time high and several left-for-dead stocks showing new life in the second half of the year. But not all rallies are created equally.

Three catalyst-driven stocks have bounced more than 30% off their 2026 lows, but each still carries fundamental questions that could complicate the rebound. Catalysts can drive stocks to unprecedented heights, but they can also mask underlying fundamental weakness, and that’s the common theme among these three summer standouts. After such sharp rebounds, is it time for investors to take profits?

Intuit: Price Hikes and Restructuring Hide Slowing Growth

Intuit Inc. (NASDAQ: INTU) has been one of the poster children of the software apocalypse, and the stock is still down more than 40% year-to-date (YTD) despite the recent rally. Investors had reason to exhale when the company reported its fiscal Q3 2026 numbers on May 20, posting earnings per share (EPS) and revenue above expectations, with sales growing more than 10% year-over-year (YOY). But as always, the underlying numbers tell the story, and much of this growth is coming from price increases, not new business.

Average revenue per user (APRU) rose 11%, with paid online units up 2%, but total online units declined 2%. Intuit is getting more cash from each customer but losing market share, especially among DIY filers earning under $50,000 annually. TurboTax Live, which offers expert advice from tax professionals, now accounts for more than 50% of the franchise’s revenue. The company laid off 17% of its workforce as a cost-cutting measure, but selling more assisted services and less software creates some potentially painful arithmetic for Intuit in fiscal 2027.

INTU shares began 2026 with a Death Cross-aided drawdown that cascaded more than 60% between January and June. But the stock is now 30% off that June low and recently broke through the 50-day moving average, which has been stiff resistance since the decline began. However, this minor technical milestone has pushed the Relative Strength Index (RSI) into overbought territory, even as the price remains well below the 200-day moving average.

Intuit reports fiscal Q4 2026 results on Aug. 25, and the market expects quarterly EPS of $1.43 and revenue of $4.28 billion. But investors and analysts will be watching the full-year guidance projections for fiscal 2027 more closely. A conservative guide will fuel the AI-disruption trade in many investors’ minds and validate the Sell rating Goldman Sachs gave the stock last year.

MGM Resorts: Decaying Premium Shows Market Considering Deal Risk

Shares of MGM Resorts International (NYSE: MGM) jumped from about $32 to $50 earlier this summer based on excitement surrounding two catalysts. First, a series of price target boosts from analysts in April and May, which included a pair of prescient upgrades from Truist Financial and KeyCorp. Then, on June 1, Barry Diller’s People Inc. offered to buy out the company for $48.30 per share, which sent the stock up more than 16% that day, closing above $50.

But since the announcement, the stock has fallen below the buyout offer price, suggesting investors are now factoring in significant deal risk. The MGM board has authorized a committee to review the offer, which would increase People Inc’s stake from 26.1% to 50.1%. Additionally, Las Vegas numbers have declined since the price-target boost parade, with visitor volume down more than 11% in June and Strip occupancy down 6.5%.

The stock is now back under its 50-day moving average, and the Moving Average Convergence Divergence (MACD) indicator shows a complete collapse in bullish momentum. The spread between current prices and the buyout offer price suggests the offer scrutiny has legitimacy, but investors should know they’re facing a merger situation, not a fundamentally broken company.

Leidos Holdings: Weak Guidance Doesn’t Support Stock Run-up

Leidos Holdings Inc. (NYSE: LDOS) reported its fiscal Q2 2026 numbers on Aug. 4 and produced some legitimately impressive stuff.

Revenue was up 7% YOY to a record $4.6 billion; the company-wide book-to-bill ratio was 1.1, with the Defense segment at 2.2; operating cash flow reached a record $793 million; and EPS and revenue guidance were raised for the rest of fiscal 2026.

However, the Health segment faces significant headwinds due to the VA’s suspension of all medical disability examination vendor incentive payments throughout the rest of the year, and the revenue guidance raise equated to roughly 0.5% at the midpoint.

Adjusted EBITDA margins declined 140 basis points YOY in Q2, and margin guidance was maintained, not raised, for the rest of fiscal 2026.

Shares of LDOS have climbed about 32% over the past month, with the Q2 report adding fuel to the rally despite unchanged margin guidance and only a modest revenue guidance increase. Analysts were also mixed on the numbers, with four target boosts, two target drops, and (most tellingly) zero upgrades.

The market may have gotten ahead of itself with the reaction to the Q2 report, and with the RSI now screaming overbought, it may be time to take profits here.

Read this article online ›